Compare SXTP & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXTP | KXIN |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 1.7M |
| IPO Year | 2023 | 2017 |
| Metric | SXTP | KXIN |
|---|---|---|
| Price | $0.49 | $2.88 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.70 | N/A |
| AVG Volume (30 Days) | 321.8K | ★ 1.4M |
| Earning Date | 11-27-2026 | 12-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,005,471.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.49 | N/A |
| 52 Week Low | $0.34 | $0.11 |
| 52 Week High | $8.62 | $22.00 |
| Indicator | SXTP | KXIN |
|---|---|---|
| Relative Strength Index (RSI) | 29.77 | 76.02 |
| Support Level | N/A | $1.13 |
| Resistance Level | $1.01 | $6.37 |
| Average True Range (ATR) | 0.11 | 0.27 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 6.02 | 92.64 |
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.